Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells

BACKGROUND: The mechanism of action of oral cladribine, recently licensed for relapsing multiple sclerosis, is unknown. OBJECTIVE: To determine whether cladribine depletes memory B cells consistent with our recent hypothesis that effective, disease-modifying treatments act by physical/functional dep...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Neurol
Autors principals: Ceronie, Bryan, Jacobs, Benjamin M., Baker, David, Dubuisson, Nicolas, Mao, Zhifeng, Ammoscato, Francesca, Lock, Helen, Longhurst, Hilary J., Giovannoni, Gavin, Schmierer, Klaus
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2018
Matèries:
Original Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5937883/
https://ncbi.nlm.nih.gov/pubmed/29550884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-018-8830-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars